What is Clearsense?
Clearsense operates at the intersection of advanced data analytics and clinical change management. The company provides a sophisticated platform designed to support the adoption of best-practice workflows through the delivery of actionable, precise, and real-time insights. By bridging the gap between raw data and clinical decision-making, Clearsense empowers healthcare organizations to optimize their operational efficiency and improve patient outcomes. Its market position is defined by its ability to integrate disparate data streams into a unified, user-centric interface, making it an essential partner for large-scale health systems navigating the complexities of digital transformation.
How much funding has Clearsense raised?
Clearsense has raised a total of $85.3M across 4 funding rounds:
Debt
$350K
Other Financing Round
$30M
Series D
$50M
Stock/Share Issuance
$5M
Debt (2020): $350K with participation from PPP
Other Financing Round (2021): $30M led by Health Catalyst Capital Management LLC
Series D (2023): $50M supported by HealthQuest Capital, Health Catalyst Capital Management, and UPMC Enterprises
Stock/Share Issuance (2026): $5M, investors not publicly disclosed
Key Investors in Clearsense
HealthQuest Capital
A growth-oriented investment firm specializing in healthcare innovation, focusing on medical devices, services, and diagnostics to improve patient outcomes.
Health Catalyst Capital Management
A private equity firm targeting high-growth healthcare information technology and tech-enabled services to drive quality and affordability in the U.S. market.
UPMC Enterprises
The innovation arm of UPMC, focused on commercializing data-driven healthcare breakthroughs and practical solutions for clinical care.
What's next for Clearsense?
With the recent influx of capital, Clearsense is well-positioned to accelerate its product roadmap and expand its market reach. The strategic focus will likely center on enhancing the platform's predictive capabilities and deepening its integration with existing electronic health record systems. As the healthcare industry continues to prioritize data-driven decision-making, Clearsense is poised to leverage its current momentum to capture additional market share. The company's ability to translate complex data into tangible clinical improvements remains its primary competitive advantage, ensuring long-term viability in an increasingly digitized healthcare ecosystem.
See full Clearsense company page
